Knight Therapeutics Inc - Significant Ownership

Signature - Title
/s/ Samira Sakhia - Samira Sakhia / President and Chief Executive Officer
Location
Montreal, Quebec, Canada
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Knight Therapeutics Inc.

Significant Ownership of Knight Therapeutics Inc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SNYR Synergy CHC Corp. Common Stock, par value $0.00001 per share 19.9% $3.54M $793K 1.91M +28.9% KNIGHT THERAPEUTICS INC. Jun 11, 2025

Schedules 13D/G Reported by Knight Therapeutics Inc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.